BFA
ACER

BlackRock Fund Advisors’s Acer Therapeutics Inc ACER Stock Holding History

BlackRock Fund Advisors’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2K Buy
239
+52
+28% +$910 ﹤0.01% 4164
2016
Q3 		$6K Buy
187
+19
+11% +$798 ﹤0.01% 4046
2016
Q2 		$7K Buy
168
+13
+8% +$387 ﹤0.01% 4046
2016
Q1 		$4K Buy
155
+29
+23% +$636 ﹤0.01% 4135
2015
Q4 		$4K Buy
+126
New +$4.17K ﹤0.01% 4186

Other funds holding ACER

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BlackRock Fund Advisors's ACER Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Acer Therapeutics Inc (ACER) stake by 28% in Q4 2016, buying an estimated $910 and bringing the position to 239 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #4164.

BlackRock Fund Advisors first reported a position in ACER in Q4 2015 and has held it in 5 quarters since. The position peaked at $7K in Q2 2016. 17 funds tracked by Wall St. Rank hold ACER as of Q4 2016.

  • BlackRock Fund Advisors held 239 shares of Acer Therapeutics Inc worth $2K as of Q4 2016.
  • BlackRock Fund Advisors bought 52 Acer Therapeutics Inc shares in Q4 2016, an estimated $910.
  • Acer Therapeutics Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4164 holding.
  • BlackRock Fund Advisors first reported a position in Acer Therapeutics Inc in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Fund Advisors's Acer Therapeutics Inc position peaked at $7K in Q2 2016.
  • 17 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.